A randomized placebo controlled trial of vitamin E for alcoholic hepatitis (Q44691206)

5 December 2017

A randomized placebo controlled trial of vitamin E for alcoholic hepatitis (English)

1 reference

5 December 2017

0 references

1 reference

5

1 reference

5 December 2017

Esteban Mezey

1

1 reference

5 December 2017

James J Potter

series ordinal

2

1 reference

5 December 2017

Lynda Rennie-Tankersley

series ordinal

3

1 reference

5 December 2017

Juan Caballeria

series ordinal

4

1 reference

5 December 2017

1 January 2004

1 reference

5 December 2017

Journal of Hepatology

1 reference

5 December 2017

40

1 reference

5 December 2017

1

1 reference

5 December 2017

40-46

1 reference

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Spin trapping evidence for alcohol-associated oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Vitamin E in humans: demand and delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Impaired vitamin E status in patients with parenchymal liver cirrhosis: relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Some aspects of antioxidant status in blood from alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Effects of long-term vitamin E supplementation in alcoholic cirrhotics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Circulating antioxidant concentrations in children with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

A simple fluorometric assay for lipoperoxide in blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

High doses of vitamin E in the treatment of disorders of the central nervous system in the aged

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Lipid peroxidation in alcoholic liver disease in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Ethanol enhances TNF-alpha-inducible NFkappaB activation and HIV-1-LTR transcription in CD4+ Jurkat T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Radioimmunoassay for type III procollagen peptide and its application to human liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900476-8

7 January 2021

10.1016/S0168-8278(03)00476-8

Identifiers

DOI

1 reference

5 December 2017

1 reference